October 4, 2022

Glaucoma treatment gets FDA OK

Pin It

From Newsmax Aerie Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration approved its eyedrop, Rhopressa, as a treatment for glaucoma, two months ahead of the expected date. Glaucoma affects about 2.7 million people in the United States and is the second leading cause of blindness in the world. Rhopressa helps lower the […]